HeartCycle Project Sets Out to Create Innovative Telemonitoring Solutions

Clothes, bed sheets and home appliances could soon help heart patients to better deal with their condition. The new EU-funded HeartCycle project sets out to create innovative telemonitoring solutions. Launched on 1 March, it is one of the largest biomedical and healthcare research projects in the EU.

The system that the industry-led research consortium is planning to develop will improve the quality of care for coronary heart disease and heart failure patients by monitoring their condition at home, using unobtrusive sensors built into everyday objects. At the same time, the system is intended to report automatically to clinicians, so that they can adapt therapies and make lifestyle recommendations, as well as involve the patients themselves in the management of their disease. The latter is a great challenge as well as a great opportunity, according to Professor John Cleland, head of the Department of Cardiology at the University of Hull, UK. "Investing directly in people who need help, and not just in services that do things to or for them, makes sense in terms of improved care, greater affordability and the effective deployment of scarce nursing and medical resources," he says.

"By developing systems that remotely monitor heart patients and motivate them to adhere to treatment regimes and adopt beneficial lifestyles, we hope to improve the survival of people with heart disease as well as contain the overall cost of care," explains Henk van Houten, senior vice president of Phillips Research and head of the Healthcare Research programme.

"The development of such systems can only be achieved efficiently via multi-disciplinary partnerships between hardware engineers, software engineers, textile manufacturers, industrial designers, clinical experts and healthcare providers, as is the case in the HeartCycle project," Mr van Houten adds.

The public and private 18 project partners from Germany, Greece, Finland, Spain, Portugal, the Netherlands, the UK, Italy, Switzerland and China come from numerous different backgrounds in research, academia, medicine and industry. Over a period of four years, the EU will invest more than €14 million in the HeartCycle research under its Seventh Framework Programme (FP7). The total project cost amounts to nearly €22 million.

HeartCycle builds on the progress made by the MyHeart project, which will end in December 2008 and received funding under the Information Society Technologies (IST) programme of the Sixth Framework Programme (FP6). MyHeart, bringing together some of the same actors, developed advanced telemonitoring technologies and service concepts to enable people to play an active role in maintaining their health. It was during this research that the project partners identified home-based disease management as a potential field for improving medical standards of care, an objective that HeartCycle is trying to achieve with a focus on coronary heart disease.

A total of 1.9 million deaths in the EU every year are the result of cardiovascular diseases, causing annual health costs of €105 billion. Half of those deaths occur in people who have previously had a heart attack, which is why the project partners consider "finding better ways to manage and treat coronary heart disease and chronic heart failure as one of the most effective ways of reducing the human cost and financial burden of these debilitating conditions."

For further information, please visit:
http://www.research.philips.com/

Related news articles:

Copyright ©European Communities, 2008
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...